Search results
'Winner of the night': 4-year-old cancer survivor has his book set to music in unique performance
Milwaukee Journal Sentinel via Yahoo News· 9 hours agoJames was rushed to the emergency room with such extreme abdominal pain he could not stand, his...
'It traps the pigment': Redditors stunned as study shows tattoos linked to deadly cancer and may...
The Daily Dot· 5 days agoInternet users have warned to extend research into the long-term health effects of tattoos after new...
Cancer patients often do better with less intensive treatment, new research finds
San Francisco Chronicle· 2 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 4 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 12 hours agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
Cancer patients often do better with less intensive treatment, new research finds - The Boston Globe
The Boston Globe· 2 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Eileen champions the fight against blood cancer in heartfelt campaign
WJLA· 5 days agoEileen is fighting for the Leukemia and Lymphoma Society with her fundraising campaign. (7News)
Even with the Sixers and ‘Nova Knicks’ gone, Philly ties to the NBA Finals are aplenty
Philly.com· 10 hours agoThe 76ers are out of the NBA playoffs. The veteran point guard spent the first four years of his NBA...
James Patterson realized Michael Crichton's vision for a volcano thriller 16 years after his death
Los Angeles Times· 4 days agoMichael Crichton, the mega-selling author and filmmaker best known for the novel “Jurassic Park,”...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 2 hours agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung cancer (NSCLC).